Displaying items 25-36 of 99
» View wsbtradio.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
•
Next >
-
U.S. files 2nd lawsuit accusing Novartis of kickbacks
ReutersApril 26 (Reuters) - The U.S. government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multi-million dollar kickbacks to doctors in exchange for prescribing its drugs....Tags: Manhattan (New York City), Government Health Care, Trials, Corporate Crime, Crime, Law and Justice
-
EEUU demanda a Novartis, alega sobornos a farmacias
ReutersPor Bernard Vaughan y Jonathan Stempel 23 abr (Reuters) - El Gobierno de Estados Unidos presentó el martes una demanda civil por fraude contra Novartis AG, acusando a la unidad de la farmacéutica suiza de causar que los programas sociales Medicare y...Tags: Manhattan (New York City), Government Health Care
-
Novartis names Harry Kirsch new CFO
ReutersZURICH, April 24 (Reuters) - Swiss drugmaker Novartis named Harry Kirsch as new Chief Financial Officer to help improve productivity as the Basel-based drugmaker looks to grow beyond a wave of patent expiries. Novartis said 48-year-old Kirsch, who joined...Tags: Alcoholic Beverages, Corporate Officers, High Blood Pressure, Patents, Copyrights and Trademarks, Diovan (drug)
-
PRESS DIGEST-New York Times business news - April 24
ReutersApril 24 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * On Tuesday, Apple Inc announced that it planned to more than double its...Tags: Crime, Law and Justice, Buyback, Air Transportation Delays, Air Transportation Industry, Federal Aviation Administration
-
Novartis busca mejoras en la productividad con nuevo director financiero
ReutersZURICH, 24 abr (Reuters) - Novartis promovió a Harry Kirsch, quien ha impulsado mejoras en la productividad en su división de productos farmacéuticos, para ser su director financiero en momentos en que la farmacéutica suiza busca crecer más allá...Tags: Diovan (drug)
-
The day ahead in business April 24
Reports: MBA mortgage index for week ended April 20, 6 a.m.; Durable goods orders for March, 7:30 a.m.; Crude inventories for week ended April 20, 9:30 a.m. Local earnings: Boeing Co., First Midwest Bancorp Inc., Horace Mann Educators Corp., Morningstar...
Tags: Zynga Inc., Boeing Co., Lilly Eli & Co, Manufacturing and Engineering, Ryland Group Incorporated
-
European shares gain on earnings boost, ECB easing hopes
Reuters* FTSEurofirst up 1.3 percent, Euro STOXX 50 up 1.5 percent * ARM and Richemont beat expected earnings * Mixed PMIs leave space for rate cut * Defensives continue to outperform By Alistair Smout LONDON, April 23 (Reuters) - European shares rose on...Tags: European Central Bank, Standard & Poor's Financial Services LLC, Earnings, STMicroelectronics NV, DAX
-
Moody's sees pick-up in pharmaceutical industry M&A in 2013
ReutersLONDON, April 23 (Reuters) - Cash-rich drug companies are likely to make more acquisitions in 2013 after a thin year for deals in 2012, ratings agency Moody's Investors Service said on Tuesday. In an review of the global sector reiterating a "stable"...Tags: Moody's Corporation, AstraZeneca Plc, Bristol Myers Squibb Company
-
INTERVIEW-South Africa seeks to close drug patent loophole
ReutersBy Wendell Roelf CAPE TOWN, April 22 (Reuters) - South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior...Tags: South Africa, Chemical Industry, Pharmaceuticals, Africa, Lobbying
-
Swiss voters say yes to 'Rip-Off Initiative' to control executive pay
Voters in Switzerland, angered by high executive pay, backed a plan to increase the control of shareholders over compensation of corporate leaders. Nearly 70% of voters approved the so-called "Rip-Off Initiative," according to the Swiss television...
Tags: Chemical Industry, CEO Pay, Pharmaceuticals, Punishment, Swiss Confederation
-
Indian court ruling hailed as victory for generic drugs
The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs. The court ruled that Glivec, the drug developed by Novartis, was...
Tags: Contracts, Trade Dispute, India, Patents, Copyrights and Trademarks, U.S. Chamber of Commerce
-
Drug maker Novartis loses India patent battle
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions...
Tags: Chemical Industry, Health Treatments, Pharmaceuticals, Crime, Law and Justice, HIV
Apr 26, 2013
|Story| Reuters
Apr 23, 2013
|Story| Reuters
Apr 23, 2013
|Story| Reuters
Apr 23, 2013
|Story| Reuters
Apr 24, 2013
|Story| Reuters
Apr 24, 2013
|Story| Chicago Tribune
Apr 23, 2013
|Story| Reuters
Apr 22, 2013
|Story| Reuters
Apr 22, 2013
|Story| Reuters
Mar 4, 2013
|Story| Los Angeles Times
Apr 1, 2013
|Story| Los Angeles Times
Mar 31, 2013
|Story| Los Angeles Times
Original site for Novartis AG topic gallery.